Location History:
- Copenhagen, DK (2006)
- Stockholm, SE (2010)
Company Filing History:
Years Active: 2006-2010
Title: Gunilla Karlsson: Innovator in Therapeutic Vaccination
Introduction
Gunilla Karlsson, a prominent inventor based in Stockholm, Sweden, has made significant contributions to the field of immunotherapy. With a portfolio of three patents, her innovative work focuses on developing therapeutic vaccination methods that harness the body's immune response against cancer.
Latest Patents
The most notable of Gunilla Karlsson's inventions is a method for inducing cell-mediated immunity against cellular antigens. This invention specifically aims to stimulate cytotoxic T-lymphocyte immunity against weak antigens, particularly self-proteins. The process involves inducing antigen-presenting cells to present at least one CTL epitope of the weak antigen while also presenting a foreign T-helper lymphocyte epitope. In preferred embodiments, the antigens are specific to cancer, such as PSM, Her2, or FGF8b. This method can be applied through traditional polypeptide vaccination, live attenuated vaccines, or nucleic acid vaccination. Additionally, the invention includes immunogenic analogues of PSM, Her2, and FGF8b, along with nucleic acid molecules encoding these analogues, as well as vectors and transformed cells used in the process. Furthermore, her work provides a method for identifying immunogenic analogues of weak or non-immunogenic antigens.
Career Highlights
Throughout her career, Gunilla Karlsson has worked with companies such as Bn Immunotherapeutics, Inc. and Pharmexa A/S. Her innovative mindset and dedication to the field of therapeutic vaccination have established her as a leader in her industry.
Collaborations
In her professional journey, Gunilla Karlsson has collaborated with notable colleagues such as Lucilla Steinaa and Søren Mouritsen. These partnerships have enriched her work and contributed to the advancement of immunotherapeutic solutions.
Conclusion
Gunilla Karlsson's innovative approach to therapeutic vaccination reflects her dedication to improving cancer treatment through advanced immunological techniques. Her patents not only showcase her inventiveness but also highlight the potential for significant advancements in the fight against cancer. As she continues her work, the impact of her inventions is likely to resonate within the medical community for years to come.